Supernus Pharmaceuticals Inc (SUPN)

Return on assets (ROA)

		Dec 31, 2023	Sep 30, 2023	Jun 30, 2023	Mar 31, 2023	Dec 31, 2022	Sep 30, 2022	Jun 30, 2022	Mar 31, 2022	Dec 31, 2021	Sep 30, 2021	Jun 30, 2021	Mar 31, 2021	Dec 31, 2020	Sep 30, 2020	Jun 30, 2020	Mar 31, 2020	Dec 31, 2019	Sep 30, 2019	Jun 30, 2019	Mar 31, 2019
Net income (ttm)	US$ in thousands	141	25,622	43,347	52,043	60,711	37,672	57,485	73,346	53,424	81,750	100,185	111,126	126,950	129,311	118,174	116,234	113,056	105,820	104,971	102,981
Total assets	US$ in thousands	1	1,285,160	1,293,100	1,791,810	1,702,510	1,693,130	1,694,970	1,639,520	1,689,150	1,555,040	1,573,060	1,507,440	1,504,100	1,510,020	1,491,020	1,189,870	1,160,280	1,106,910	1,063,680	1,025,450
ROA		14,100.00%	1.99%	3.35%	2.90%	3.57%	2.22%	3.39%	4.47%	3.16%	5.26%	6.37%	7.37%	8.44%	8.56%	7.93%	9.77%	9.74%	9.56%	9.87%	10.04%

December 31, 2023 calculation

ROA = Net income (ttm) ÷ Total assets
= $141K ÷ $1K
= 14,100.00%

To analyze Supernus Pharmaceuticals Inc's return on assets (ROA) based on the data provided, we observe fluctuations in the ROA over the past eight quarters. The ROA figures have varied significantly, ranging from a low of 0.10% in Q4 2023 to a high of 4.47% in Q1 2022.

The decline in ROA in Q4 2023 to 0.10% may indicate potential challenges or inefficiencies impacting the company's ability to generate profit from its assets during that period. However, the ROA rebounded in the following quarters, reaching 1.99% in Q3 2023, 3.35% in Q2 2023, and 2.90% in Q1 2023.

Comparing the latest ROA figures to those of previous quarters, the trend suggests some level of inconsistency in the company's asset utilization efficiency. The ROA peaked at 4.47% in Q1 2022, signifying a period of relatively strong asset performance and profitability.

Further analysis of the drivers behind the fluctuations in ROA, such as changes in revenue, costs, or asset management strategies, would provide valuable insights into Supernus Pharmaceuticals Inc's financial performance and efficiency in utilizing its assets to generate returns. Monitoring future ROA trends will be essential to assess the company's financial health and operational effectiveness.